Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?

Annals of Surgery

Volumn 229, Issue 4, 1999, Pages 536-541

  Chu, Kyo U ^a   Turner, Roderick R ^a   Hansen, Nora M ^a   Brennan, Meghan B ^a   Bilchik, Anton ^a   Giuliano, Armando E ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TREATMENT INDICATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED;

EID: 0033504887     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199904000-00013     Document Type: Article

References (24)

1. Wilking N, Rutqvist LE, Carstensen J, Mattsson A, Skoog L. Prognostic significance of axillary nodal status in primary breast cancer in relation to the number of resected nodes. Acta Oncol 1992; 31:29-35.
2. Moore MP, Kinne DW. Axillary lymphadenectomy: a diagnostic and therapeutic procedure. J Surg Oncol 1997; 66:2-6.
3. Cady B. Case against axillary lymphadenectomy for most patients with infiltrating breast cancer. J Surg Oncol 1997; 66:7-10.
4. White RE, Vezeridis MP, Konstadoulakis M, Cole BF, Wanebo HJ, Bland KI. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions. J Am Coll Surg 1996; 183:575-582.
5. Chontos AJ, Maher DP, Ratzer ER, Fenoglio ME. Axillary lymph node dissection: is it required in T1a breast cancer? J Am Coll Surg 1997; 184:493-498.
6. Fein DA, Fowble BL, Hanlon AL, et al. Identification of women with T1-T2 breast cancer at low risk of positive axillary nodes. J Surg Oncol 1997; 65:34-39.
7. Whitten TM, Fraser HR, Christensen WN, Turk PS. Axillary lymph node metastasis in stage T1a breast cancer: a pathologic review of 82 patients. Am Surg 1997; 63:144-149.
8. Giuliano AE, Barth AM, Spivack B, Beitsch PD, Evans SW. Incidence and predictors of axillary metastasis in T1 carcinoma of the breast. J Am Coll Surg 1996; 183:185-189.
9. Shetty MR. Axillary lymph node metastasis in carcinoma of the breast. J Am Coll Surg 1997; 184:671-673.
10. Recht A, Houlihan MJ. Axillary lymph nodes and breast cancer. Cancer 1995; 76:1491-1512.
11. Giuliano AE, Kirgan DM, Guenther M, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220:391-401.
12. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995; 222:394-401.
13. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997; 15:2345-2350.
14. Turner RR, Ollila DW, Krasne DL, Giuliano AE. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 1997; 226:271-278.
15. Fleming ID, Cooper JS, Henson DE, et al. AJCC cancer staging manual, 5th ed. Philadelphia: Lippincott-Raven; 1997:171-180.
16. Veronesi U, Paganelli G, Galimherti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997; 349:1864-1867.
17. Quiet CA, Ferguson DJ, Weichselbaum RR, Hellman S. Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up. J Clin Oncol 1995; 13:1144-1151.
18. Mustafa IA, Cole B, Wanebo HJ, Bland KI, Chang HR. The impact of histopathology on nodal metastases in minimal breast cancer. Arch Surg 1997; 132:384-390.
19. Barth A, Craig PH, Silverstein MJ. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Cancer 1997; 79: 1918-1922.
20. Shetty MR, Reiman HM Jr. Tumor size and axillary metastasis, a correlative occurrence in 1244 cases of breast cancer between 1980 and 1995. Eur J Surg Oncol 1997; 23:139-141.
21. Cady B. Use of primary breast carcinoma characteristics to predict lymph node metastases. Cancer 1997; 79:1856-1861.
22. Ludwig Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 1990; 335:1565-1568.
23. Clare SE, Sener SF, Wilkens W, Goldschmidt R, Merkel D, Winchester DJ. Prognostic significance of occult lymph node metastases in node-negative breast cancer. Ann Surg Oncol 1997; 4:447-451.
24. Dowlatshahi K, Fan M, Snider HC, Habib FA. Lymph node micrometastasis from breast carcinoma. Cancer 1997; 80:1188-1197.